Mark A. Lovell
Department of Chemistry
Sanders-Brown Center on Aging and Alzheimer's Disease Center
University of Kentucky
Lexington
USA
Name/email consistency: high
- An aberrant protein complex in CSF as a biomarker of Alzheimer disease. Lovell, M.A., Lynn, B.C., Xiong, S., Quinn, J.F., Kaye, J., Markesbery, W.R. Neurology (2008)
- Oxidatively modified RNA in mild cognitive impairment. Lovell, M.A., Markesbery, W.R. Neurobiol. Dis. (2008)
- Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Lovell, M.A., Markesbery, W.R. Nucleic Acids Res. (2007)
- Oxidative damage in mild cognitive impairment and early Alzheimer's disease. Lovell, M.A., Markesbery, W.R. J. Neurosci. Res. (2007)
- Elevated zinc transporter-6 in mild cognitive impairment, Alzheimer disease, and pick disease. Lovell, M.A., Smith, J.L., Markesbery, W.R. J. Neuropathol. Exp. Neurol. (2006)
- Amyloid beta peptide, 4-hydroxynonenal and apoptosis. Lovell, M.A., Markesbery, W.R. Current. Alzheimer. Research (2006)
- Quantitative proteomic analysis of mitochondria from primary neuron cultures treated with amyloid beta peptide. Lovell, M.A., Xiong, S., Markesbery, W.R., Lynn, B.C. Neurochem. Res. (2005)
- Ectopic expression of Musashi-1 in Alzheimer disease and Pick disease. Lovell, M.A., Markesbery, W.R. J. Neuropathol. Exp. Neurol. (2005)
- Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3. Lovell, M.A., Xiong, S., Xie, C., Davies, P., Markesbery, W.R. J. Alzheimers Dis. (2004)
